New drug provides hope for older people with Parkinsons
Research in the journal Plos One has suggested that a type of diabetes drug may offer some hope in helping people with Parkinson’s disease.
Scientists have found that people taking glitazone pills were less likely to develop Parkinson’s than people taking other diabetes drugs. However, they have cautioned that the drugs could have serious side-effects and shouldn’t be given to people in full health, reports the BBC.
It is hoped these findings should prompt further research.
Dr Ian Douglas, lead researcher at the London School of Hygiene and Tropical Medicine, said: “We often hear about negative side-effects associated with medications, but sometimes there can also be unintended beneficial effects. Our findings provide unique evidence that we hope will drive further investigation into potential drug treatments for Parkinson’s disease.”
Dr Arthur Roach, from the charity Parkinson’s UK, added: “Hopefully the results of this study will spark further research into developing drugs that work in a similar way to glitazone drugs, and have the ability to reduce someone’s chance of developing Parkinson’s.”
Introduction The National Statement of Expectations for Supported Housing (NSE) was finally published on 20 October 2020, five years after the 2015 Comprehensive Spending Review suggested regulatory and oversight changes were needed, although in 2018 the government >>>
How to fund Housing Support and Social Care Services
"Alot of information in a short time, good for me because I travelled a long way. So I feel the journey was worthwhile."
C.T - People First Dorset